欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IS/H/0420/001
药品名称Eleber
活性成分
    • Cabazitaxel 60.0 mg
剂型Concentrate and solvent for solution for infusion
上市许可持有人Zentiva k.s. U kabelovny 130, Dolní Měcholupy, 102 37 Prague 10, Czech Republic
参考成员国 - 产品名称Iceland (IS)
Eleber
互认成员国 - 产品名称
    • Poland (PL)
      Cabazitaxel Alvogen
    • Latvia (LV)
      Eleber 60 mg koncentrāts un šķīdinātājs infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Eleber 60 mg koncentratas ir tirpiklis infuziniam tirpalui
    • Estonia (EE)
      ELEBER
    • Hungary (HU)
      ELEBER
    • Bulgaria (BG)
      Cabazitaxel Alvogen
    • Czechia (CZ)
      Cabazitaxel Alvogen
    • Romania (RO)
      Cabazitaxel Alvogen 60 mg concentrat şi solvent pentru soluţie perfuzabilă
    • Slovakia (SK)
      Eleber 60 mg koncentrát a rozpúšťadlo na infúzny roztok
    • Slovenia (SI)
    • Croatia (HR)
      Eleber 60 mg koncentrat i otapalo za otopinu za infuziju
许可日期2021/03/18
最近更新日期2023/11/14
药物ATC编码
    • L01CD04 cabazitaxel
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase